The miRoncol Real-time Multi-Cancer Early Risk Assessment is not only designed for individuals it’s also a valuable tool for healthcare providers, clinics, and organizations committed to proactive health. By partnering with miRoncol, you can bring real-time molecular insight into your programs, complementing conventional screening and physician-led care.
Adds molecular-level risk awareness to preventive care.
Solid science with specificity above 99% and strong sensitivity across many common cancers.
Can be included in annual checkups, executive health packages, or integrative wellness programs.
Designed to complement, not replace, conventional diagnostics and physician judgment.
Support patients who want proactive cancer risk assessment beyond routine panels.
Offer discerning clients molecular insights that complement MRI, genomics, and longevity programs.
Incorporate molecular signals into preventive and lifestyle-focused care.
Use science-backed tools to motivate evidence-informed wellness strategies.
Add real-time molecular risk assessment to programs focused on aging and prevention.
Collaborate on awareness, education, and equity in early detection.
miRoncol partnerships are built on trust, scientific rigor, and a shared commitment to prevention. Together, we can make meaningful early detection more accessible.